HoffmannS., EdlerL., GardnerI., GribaldoL., HartungT., KleinC., LiebschM., SauerlandS., SchechtmanL., StammatiA. & NikolaidisE. (2008). Points of reference in the validation process. The report and recommendations of ECVAM Workshop 66. ATLA36, 343–352.
2.
HoffmannS., SalinerA.G., PatlewiczG., EskesC., ZuangV. & WorthA.P. (2008). A feasibility study developing an integrated testing strategy assessing skin irritation potential of chemicals. Toxicology Letters (E-publication — ahead of printing).
3.
StummannT.C., HarengL. & BremerS. (2008). Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells. Toxicology (E-publication — ahead of printing).
4.
GstraunthalerG. (2003). Alternatives to the use of fetal bovine serum: Serum-free cell culture. ALTEX20, 275–281.
5.
RauchC., FeifelE., SchöfflH., PfallerW. & GstraunthalerG. (2007). Alternatives to the use of fetal bovine serum: Platelet lysates as serum replacement in cell and tissue culture. ALTEX24, 353.
6.
EvenM.S., SanduskyC.B. & BarnardN.B. (2006). Serum-free hybridoma culture: ethical, scientific and safety considerations. Trends in Biotechnology24, 105–108.
7.
CoeckeS., BallsM., BoweG., DavisJ., GstraunthalerG., HartungT., HayR., MertenO.W., PriceA., SchechtmanL., StaceyG. & StokesW. (2006). Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice. ATLA33, 261–287.